SARS-COV-2 reagent kit SOLIScript® SARS-CoV-2 RT-qPCR Multiplex Assay Kit (IVD)

DNA polymerasedNTP solutionbuffer solution

The SOLIScript® SARS-CoV-2 RT-qPCR Multiplex Assay Kit is an in vitro qualitative diagnostic test intended for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genetic material in biological samples obtained from the upper respiratory tract (nasopharyngeal swabs). The SOLIScript® SARS-CoV-2 RT-qPCR Multiplex Assay Kit is designed for simultaneous detection of three distinct regions in SARS-CoV-2 genome: Nucleocapsid gene (N), Envelope gene (E) and RNA-dependent RNA polymerase gene (RdRP), as well as human RNase P transcript (RPP30). Highly specific and sensitive assay design enables accurate detection of all circulating SARS-CoV-2 Variants of Concern (VOC) and Variants of Interest (VOI), including Delta (B.1.617.2) and Omicron (BA.1, BA.2, BA.4, BA.5). Description SOLIScript SARS-CoV-2 RT-qPCR Multiplex Assay Kit is an in vitro qualitative diagnostic test for multiplex detection of three distinct regions of SARS-CoV-2 genome (N, E, RdRP) along with an internal control (human Rnase P transcript) from nasopharyngeal swab samples. Excellent sensitivity and precision (LoD of 10 copies per reaction). Clinical sample testing presented 100% concordance when compared to validated reference assay (45/45 positive and 24/24 negative). No cross-reactivity with SARS-CoV-2 near-neighbour species/strains and other respiratory pathogens. Accurate detection of all circulating SARS-CoV-2 Variants of Concern (VOC) and Variants of Interest (VOI) including Delta (B.1.617.2) and Omicron (BA.1, BA.2, BA.4, BA.5). Fast turnaround time after RNA extraction: BioRad CFX96 one-step RT-qPCR test results in one hour.